RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD)

CUSIP: 75955J402

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock ($.001 par value)
Shares outstanding
74,702,121
Total 13F shares
12,376,687
Share change
-1,155,000
Total reported value
$40,240,571
Put/Call ratio
60%
Price per share
$3.24
Number of holders
69
Value change
-$3,630,516
Number of buys
16
Number of sells
40

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 75955J402?
CUSIP 75955J402 identifies RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
1.7%
1,256,705
$3,770,115 30 Jun 2024
13F
Deep Track Capital, LP
13F
Company
1.7%
1,234,773
$3,704,319 30 Jun 2024
13F
Vestal Point Capital, LP
13F
Company
1.6%
1,200,000
$3,600,000 30 Jun 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
1.6%
1,193,333
$3,577,000 30 Jun 2024
13F
FRANKLIN RESOURCES INC
13F
Company
1.4%
1,012,661
$3,037,983 30 Jun 2024
13F
PARSONS CAPITAL MANAGEMENT INC/RI
13F
Company
1.3%
975,945
$2,927,835 30 Jun 2024
13F
Palo Alto Investors LP
13F
Company
0.98%
732,400
$2,197,200 30 Jun 2024
13F
Opaleye Management Inc.
13F
Company
0.8%
600,000
$1,800,000 30 Jun 2024
13F
BlackRock Finance, Inc.
13F
Company
0.77%
573,314
$1,719,942 30 Jun 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.47%
352,616
$1,057,848 30 Jun 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.39%
292,500
$877,500 30 Jun 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.35%
260,498
$781,692 30 Jun 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.32%
237,874
$713,622 30 Jun 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.3%
224,846
$674,538 30 Jun 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.28%
207,969
$623,907 30 Jun 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.27%
203,261
$609,783 30 Jun 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.24%
181,077
$543,231 30 Jun 2024
13F
RBF Capital, LLC
13F
Company
0.22%
165,474
$496,422 30 Jun 2024
13F
MARSHALL WACE, LLP
13F
Company
0.21%
156,619
$469,857 30 Jun 2024
13F
GROUP ONE TRADING LLC
13F
Company
0.2%
148,927
$446,781 30 Jun 2024
13F
BARCLAYS PLC
13F
Company
0.2%
145,999
$437,997 30 Jun 2024
13F
UBS Group AG
13F
Company
0.17%
128,800
$386,400 30 Jun 2024
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.14%
108,115
$324,000 30 Jun 2024
13F
STATE STREET CORP
13F
Company
0.14%
105,879
$317,637 30 Jun 2024
13F
MGO ONE SEVEN LLC
13F
Company
0.13%
100,000
$300,000 30 Jun 2024
13F
SILVERARC CAPITAL MANAGEMENT, LLC
13F
Company
0.13%
99,379
$298,137 30 Jun 2024
13F
FEDERATED HERMES, INC.
13F
Company
0.13%
96,010
$288,030 30 Jun 2024
13F
AdvisorShares Investments LLC
13F
Company
0.12%
90,028
$276,386 30 Jun 2024
13F
FMR LLC
13F
Company
0.12%
90,359
$271,077 30 Jun 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.12%
88,775
$266,325 30 Jun 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.11%
84,313
$252,939 30 Jun 2024
13F
NORTHERN TRUST CORP
13F
Company
0.11%
78,975
$236,925 30 Jun 2024
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.11%
78,893
$236,679 30 Jun 2024
13F
apricus wealth, LLC
13F
Company
0.11%
78,862
$236,586 30 Jun 2024
13F
Guild Investment Management, Inc.
13F
Company
0.1%
73,596
$220,788 30 Jun 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.1%
73,400
$220,192 30 Jun 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.09%
68,136
$204,408 30 Jun 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.09%
64,357
$193,071 30 Jun 2024
13F
CITIGROUP INC
13F
Company
0.08%
62,951
$188,853 30 Jun 2024
13F
ADAR1 Capital Management, LLC
13F
Company
0.07%
50,601
$151,803 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
0.06%
46,176
$138,528 30 Jun 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0.06%
41,270
$123,000 30 Jun 2024
13F
Ikarian Capital, LLC
13F
Company
0.05%
40,369
$121,107 30 Jun 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.05%
37,476
$112,428 30 Jun 2024
13F
SEI INVESTMENTS CO
13F
Company
0.05%
36,320
$108,960 30 Jun 2024
13F
Squarepoint Ops LLC
13F
Company
0.05%
35,425
$106,275 30 Jun 2024
13F
AlTi Global, Inc.
13F
Company
0.04%
31,975
$95,925 30 Jun 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.04%
31,618
$94,854 30 Jun 2024
13F
World Investment Advisors
13F
Company
0.04%
30,684
$92,052 30 Jun 2024
13F
HORIZON KINETICS ASSET MANAGEMENT LLC
13F
Company
0.04%
30,000
$90,000 30 Jun 2024
13F

Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) as of Q3 2024

As of 30 Sep 2024, RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) was held by 69 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,376,687 shares. The largest 10 holders included FRANKLIN RESOURCES INC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, PARSONS CAPITAL MANAGEMENT INC/RI, Palo Alto Investors LP, Deep Track Capital, LP, BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, Vestal Point Capital, LP, and Opaleye Management Inc.. This page lists 69 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
78
Q3 2024 holders
69
Holder diff
-9
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.